Taxes (Tables)

12 Months Ended

Dec. 30, 2023

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Domestic and Foreign

The components of the Company’s consolidated (loss) income before income taxes consist of the following:

	Fiscal Year Ended
	December 30,			December 31,			January 1,
	2023			2022			2022
Domestic	$	(222,260	)	$	(376,710	)	$	(27,451	)
Foreign		148,628			9,907			104,428
	$	(73,632	)	$	(366,803	)	$	76,977

Schedule of Components of Income Tax Expense (Benefit)

The following table summarizes the Company’s consolidated provision for (benefit from) U.S. federal, state and foreign income taxes:

	Fiscal Year Ended
	December 30,			December 31,			January 1,
	2023			2022			2022
Current:
U.S. federal	$	1,330		$	12,426		$	117
State		1,947			3,446			1,055
Foreign		15,525			20,022			24,245
	$	18,802		$	35,894		$	25,417
Deferred:
U.S. federal	$	(12,419	)	$	(110,611	)	$	(8,510	)
State		4,263			(23,213	)		(9,589	)
Foreign		27,977			(12,005	)		2,534
	$	19,821		$	(145,829	)	$	(15,565	)
Total provision for (benefit from) income taxes	$	38,623		$	(109,935	)	$	9,852

Schedule of Effective Income Tax Rate Reconciliation

The difference between the U.S. federal statutory tax rate and the Company’s consolidated effective tax rate is as follows:

	Fiscal Year Ended
	December 30,			December 31,			January 1,
	2023			2022			2022
U.S. federal statutory tax rate		21.0	%		21.0	%		21.0	%
State income taxes (net of federal benefit)		12.8	%		3.8	%		(1.8	%)
Research and development credit		3.0	%		0.4	%		(1.8	%)
Tax windfall/shortfall on share-based awards		(0.9	%)		(0.5	%)		(4.6	%)
Reserves for uncertain tax positions		0.0	%		0.0	%		0.2	%
Tax rate changes		(0.1	%)		0.3	%		(8.1	%)
Executive compensation limitation		(1.4	%)		(0.2	%)		1.8	%
FDII		3.6	%		1.2	%		0.0	%
Change in valuation allowance		(72.8	%)		(7.1	%)		(2.0	%)
Impact of foreign operations		(16.5	%)		(1.6	%)		8.9	%
Reversal of certain deferred tax liabilities		0.0	%		12.5	%		0.0	%
Nondeductible costs		(1.3	%)		0.0	%		0.0	%
Other		0.1	%		0.2	%		(0.8	%)
Total effective tax rate		(52.5	%)		30.0	%		12.8	%

Schedule of Deferred Tax Assets and Liabilities

The deferred tax assets and liabilities recorded on the Company’s consolidated balance sheets are as follows:

	December 30, 2023			December 31, 2022
Interest expense disallowance	$	76,350		$	54,259
Operating lease liabilities		16,174			22,076
Operating loss carryforwards		12,446			10,102
Provision for estimated expenses		3,657			2,815
Salaries and wages		13,489			10,282
Share-based compensation		14,920			15,190
Other comprehensive income		3,833			1,841
Other		4,287			4,211
Less: valuation allowance		(89,801	)		(35,818	)
Total deferred tax assets	$	55,355		$	84,958
Goodwill and intangible assets	$	(47,323	)	$	(54,588	)
Operating lease assets		(13,285	)		(19,270	)
Depreciation		(12,749	)		(13,498	)
Termination fee		(3,408	)		—
Prepaid expenses		(900	)		(440	)
Total deferred tax liabilities	$	(77,665	)	$	(87,796	)
Net deferred tax liabilities	$	(22,310	)	$	(2,838	)

Schedule of Unrecognized Tax Benefit Roll Forward

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

	Fiscal Year Ended
	December 30,			December 31,			January 1,
	2023			2022			2022
Balance at beginning of year	$	611		$	1,055		$	851
Increases related to tax positions taken in current year		—			145			196
Increases related to tax positions taken in prior years		9			8			260
Reductions related to tax positions taken in prior years		(9	)		(95	)		(199	)
Reductions related to settlements with tax authorities		—			(273	)		—
Reductions related to lapse of statutes of limitations		—			(206	)		—
Effects of foreign currency translation		2			(23	)		(53	)
Balance at end of year	$	613		$	611		$	1,055